Latest AI and machine learning research in brain cancer for healthcare professionals.
Artificial intelligence (AI) is poised to fundamentally transform radiation medicine, with growing influence across clinical decision-making, workflow efficiency, personalization of care, and quality assurance. While the technical potential of AI is well described in the literature, less attention has been given to how these tools should be responsibly implemented within real-world healthcare syst...
Despite prior success in classifying recurrent glioma noninvasively with multi-parametric MRI and AI, clinical applicability has yet to be demonstrated due to a lack of robust model evaluation and spatial preservation of tumor characteristics. This study develops, robustly evaluates, and clinically validates an interpretable model for predicting recurrent tumors from spatially varying, histopathol...
BACKGROUND: Although fibroblast growth factor receptor (FGFR) inhibitors (FGFRi) have demonstrated clinical promise, the inevitable emergence of acqui...
BACKGROUND: To develop and validate a multimodal deep learning model for pre-treatment prediction of radiation-induced temporal lobe injury (RTLI), an...
Pediatric low-grade gliomas (pLGGs), the most common CNS tumors in children, are increasingly recognized as chronic diseases with prolonged courses an...
Releases from nuclear or radiological security events can result in significant internal radiation contamination through inhalation of particulate con...
Glioblastoma is a highly aggressive brain tumor characterized by complex genetic, molecular, and epigenetic features that present significant challeng...
BACKGROUND AND PURPOSE: The delineation of contrast enhancement in pediatric brain tumors is crucial for effective surgical and treatment planning, as...
Identifying reproducible, interpretable prognostic signals from high-dimensional transcriptomics remains challenging because gene-level models often i...
Glioblastoma (GBM) remains one of the most aggressive primary brain tumors with limited therapeutic options. Cuproptosis, a recently identified copper...
Bisphenol A (BPA), a pervasive environmental endocrine disruptor, its role in glioma progression is unclear. We sought to elucidate how BPA influences...
The increasing use of nuclear technology in medicine, industry, and energy requires effective durable radiation shielding. This study aimed to develop...
BACKGROUND: Refined risk stratification before randomization is clinically important for reducing prognostic imbalance across study arms when evaluati...
OBJECTIVE: To investigate MRI-based radiomic features in glioma and key genes related to IDH mutations, and to analyze their correlation. METHODS: 61 ...
Homologous recombination deficiency (HRD) assays are used to select patients with ovarian cancer for PARP inhibitors, but they do not fully capture th...
Glioblastoma (GBM) is characterized by profound intratumoral heterogeneity and an immunosuppressive microenvironment that drive therapeutic resistance...
Pediatric glioblastoma (pGBM) is an aggressive central nervous system (CNS) tumor whose pathological progression is significantly influenced by exosom...
BACKGROUND: Glioblastoma (GBM) remains one of the most lethal adult primary brain tumors, and neurosurgical decision-making increasingly depends on in...
Clinical translation in glioma and glioblastoma remains inefficient despite advances in computational drug discovery. An underrecognized contributor t...
The FORUM (Far-infrared Outgoing Radiation Understanding and Monitoring) mission will provide, for the first time, systematic far-infrared spectral me...